Concepedia

Kei Miyakawa

KM

44

Publications

1.7K

Citations

22

H-Index

1992

Active since

Affiliations

Yokohama City University(Current)

National Institute of Infectious Diseases

Life Science Institute

Kanto Chemical (Japan)

Yokohama City University Hospital

Kei Miyakawa is an author at Yokohama City University specializing in medicine, virology, and immunology.

ORCID

Top concepts

Publications per year

1992–2022

44

Publications

44

Potent antiviral effect of silver nanoparticles on SARS-CoV-2

Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Takeshi Morita et al. · Biochemical and Biophysical Research Communications · 2020 · 422 citations · Full text

, , +4

Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells

Yunzhong Nie, Yun‐Wen Zheng, Kei Miyakawa et al. · EBioMedicine · 2018 · 174 citations · Full text

HBx-induced degradation of Smc5/6 complex impairs homologous recombination-mediated repair of damaged DNA

Kazuma Sekiba, Motoyuki Otsuka, Kazuyoshi Funato et al. · Journal of Hepatology · 2021 · 94 citations · Full text

Galectin-9 restricts hepatitis B virus replication via p62/SQSTM1-mediated selective autophagy of viral core proteins

Kei Miyakawa, Mayuko Nishi, Michinaga Ogawa et al. · Nature Communications · 2022 · 76 citations · Full text

, , +19

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests

Yutaro Yamaoka, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah et al. · Cell Reports Medicine · 2021 · 54 citations · Full text

, , +17

Rows per page

1–5 of 44